Study tracks early adoption of liver histotripsy treatment
It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology's adoption and ...
Aug 28, 2026
0
3









